Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2020 May Health Innovation Liège startup plays key part in fight against corona by easing sharing of medical images betw... Read more
2020 April Corona Remdesivir: existing Ebola treatment appears to speed up recovery process in COVID-19 patients Read more
2020 April Medical Research ImmunoSep: Europe’s strategy to reducing sepsis mortality by personalized immune therapy Read more
2020 April Clinical trials Rituximab in treatment of elderly patients with mantle cell lymphoma Read more
Top
